WuXi Waylaid
When Congress resumes next month, the BioSecure Act will be one of its top priorities. The bill, which could dramatically reorder the global pharmaceutical supply...
Showing 517 - 528 of 1778
David Zweig on the Academic Chill Between the U.S. and China
The social scientist and author discusses the fallout from the Trump administration’s China Initiative and how the U.S. should approach academic links with its strategic...
China’s Chip Consolidation
Beijing is weeding out bad actors in the semiconductor industry and concentrating its resources on well-established firms.
Clean Tech 2.0
Can the U.S. leapfrog China on green tech?
Who’s Who in the Rare Earth Industry
China has a virtual monopoly over midstream processing of rare earths.
The Green Leap
From solar panels to electric vehicles, China dominates several of the technologies needed for the green energy transition. But can the U.S. find a way...
China Must Rein in Local Governments
The decentralization of decision-making was essential to China’s economic boom in its early years, but further economic reform will require the central government to reassert...
Walz’s China Chops
A look at Tim Walz's China background.
The Smart Path to Food Security
China lacks land for farming, but companies are pursuing new technologies to help get the most produce out of every acre.
Dmitri Alperovitch on Speeding Up Efforts to Deter China
The geopolitics analyst says Xi Jinping is bent on invading Taiwan and the U.S. needs to unite with its allies to win a new Cold...
Tipping the Scales
The Ozempic craze hits China.
China’s Ozempic Test
Novo Nordisk, the maker of Ozempic, has enjoyed a China boom in recent years, commanding 77 percent of the market. But that kind of dominance...